| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $82.3M | +61.0% |
| SG&A Expense | $24.7M | +21.2% |
| Operating Income | -$107.0M | -49.7% |
| Income Tax | $1K | — |
| Net Income | -$104.8M | -47.4% |
| EPS (Basic) | -$2.62 | -45.6% |
| EPS (Diluted) | -$2.62 | -45.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.7M | +71.6% |
| Short-term Investments | $180.7M | -33.9% |
| Current Assets | $208.9M | -28.1% |
| Total Assets | $215.6M | -27.1% |
| Current Liabilities | $16.5M | +83.5% |
| Total Liabilities | $18.1M | +59.1% |
| Stockholders' Equity | $197.5M | -30.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82.1M | -61.9% |
| Capital Expenditures | $363K | -77.0% |
| Investing Cash Flow | $91.5M | +133.2% |
| Financing Cash Flow | $476K | -65.8% |
| Free Cash Flow | -$82.4M | -57.7% |